CORD-19:2008f024274c53b0de1276f4047a6a641813fd98 / 69858-70008
Annnotations
CORD-19-Sentences
{"project":"CORD-19-Sentences","denotations":[{"id":"T94665","span":{"begin":0,"end":150},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Patients on daclizumab demonstrated decreased peripheral eosinophil counts from baseline to week 20 (-30±20 /mm 3 vs. placebo +60±30 /mm 3 , p=0.004)."}
CORD-19_Custom_license_subset
{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T176","span":{"begin":0,"end":150},"obj":"Sentence"}],"text":"Patients on daclizumab demonstrated decreased peripheral eosinophil counts from baseline to week 20 (-30±20 /mm 3 vs. placebo +60±30 /mm 3 , p=0.004)."}